Javascript must be enabled to continue!
Non-tumoral uptake of 68Ga-FAPI-04 PET: A retrospective study
View through CrossRef
ObjectiveFibroblast activation protein (FAP)-targeting radiopharmaceutical based on the FAP-specific inhibitor (FAPI) is considered as a potential alternative agent to FDG for tumor-specific imaging. However, FAP is also expressed in normal adult tissues. The aim of this study was to explore the image features of non-tumoral regions with high uptake of 68Ga-FAPI-04 in positron emission tomography (PET) imaging and to reveal the physiological mechanisms of these regions.MaterialA total of 137 patients who underwent whole-body 68Ga-FAPI-04 PET/MR (n=46) or PET/CT (n=91) were included in this retrospective study. Three experienced nuclear medicine physicians determined the non-tumoral regions according to other imaging modalities (CT, MRI, 18F-FDG PET, or ultrasound), clinical information, or pathological results. The regions of interest (ROIs) were drawn manually, and the maximum standardized uptake value (SUVmax) was measured.ResultsA total of 392 non-tumoral uptake regions were included in this study. The included physiological regions were uterus (n=38), submandibular gland (n=118), nipple (n=37), gingiva (n=65), and esophagus (n=31). The incidence of 68Ga-FAPI-04 uptake in physiological regions was independent of age, the tracer uptakes in the gingiva and esophagus were more common in male patients (p=0.006, 0.009), while that in the nipple was more common in female patients (p < 0.001). The included benign regions were inflammatory lymph node (n =10), pneumonia (n=13), atherosclerosis (n=10), pancreatitis (n=18), osteosclerosis (n=45), and surgical scar (n=7). No significant difference was observed in SUVmax between physiological and benign regions.ConclusionsA number of organs exhibit physiological uptakes of 68Ga-FAPI-04. Our study showed that regions with high 68Ga-FAPI-04 uptake did not necessarily represent malignancy. Being familiar with physiological and typical benign 68Ga-FAPI-04 uptake regions can be helpful for physicians to interpret images and to make an accurate diagnosis.
Frontiers Media SA
Title: Non-tumoral uptake of 68Ga-FAPI-04 PET: A retrospective study
Description:
ObjectiveFibroblast activation protein (FAP)-targeting radiopharmaceutical based on the FAP-specific inhibitor (FAPI) is considered as a potential alternative agent to FDG for tumor-specific imaging.
However, FAP is also expressed in normal adult tissues.
The aim of this study was to explore the image features of non-tumoral regions with high uptake of 68Ga-FAPI-04 in positron emission tomography (PET) imaging and to reveal the physiological mechanisms of these regions.
MaterialA total of 137 patients who underwent whole-body 68Ga-FAPI-04 PET/MR (n=46) or PET/CT (n=91) were included in this retrospective study.
Three experienced nuclear medicine physicians determined the non-tumoral regions according to other imaging modalities (CT, MRI, 18F-FDG PET, or ultrasound), clinical information, or pathological results.
The regions of interest (ROIs) were drawn manually, and the maximum standardized uptake value (SUVmax) was measured.
ResultsA total of 392 non-tumoral uptake regions were included in this study.
The included physiological regions were uterus (n=38), submandibular gland (n=118), nipple (n=37), gingiva (n=65), and esophagus (n=31).
The incidence of 68Ga-FAPI-04 uptake in physiological regions was independent of age, the tracer uptakes in the gingiva and esophagus were more common in male patients (p=0.
006, 0.
009), while that in the nipple was more common in female patients (p < 0.
001).
The included benign regions were inflammatory lymph node (n =10), pneumonia (n=13), atherosclerosis (n=10), pancreatitis (n=18), osteosclerosis (n=45), and surgical scar (n=7).
No significant difference was observed in SUVmax between physiological and benign regions.
ConclusionsA number of organs exhibit physiological uptakes of 68Ga-FAPI-04.
Our study showed that regions with high 68Ga-FAPI-04 uptake did not necessarily represent malignancy.
Being familiar with physiological and typical benign 68Ga-FAPI-04 uptake regions can be helpful for physicians to interpret images and to make an accurate diagnosis.
Related Results
SEMANA DE ENFERMAGEM E SEUS ASPECTOS SOCIAIS NA VALORIZAÇÃO PROFISSIONAL: UM RELATO DE EXPERIÊNCIA DO GRUPO PET-ENFERMAGEM
SEMANA DE ENFERMAGEM E SEUS ASPECTOS SOCIAIS NA VALORIZAÇÃO PROFISSIONAL: UM RELATO DE EXPERIÊNCIA DO GRUPO PET-ENFERMAGEM
A enfermagem é o pilar da assistência pois está na linha de frente do cuidado holístico, todavia esta é estigmatizada e desvalorizada, assim como não possui reconhecimento consider...
Diagnostic performance of Ga-68 FAPI 04 PET/CT in colorectal malignancies
Diagnostic performance of Ga-68 FAPI 04 PET/CT in colorectal malignancies
Aim
To evaluate the role of Ga-68 fibroblast activation protein inhibitor 04 PET/computed tomography (FAPI) in colorectal cancers (CRCs) in terms of diagnostic accuracy...
Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression
Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression
Abstract
Background: recently it has been identified a short peptide that showed allosteric antagonism against C-C motif chemokine receptor 2 (CCR2) expressed on inflammato...
Comparative study of total-body PET and PET/MR in the diagnosis of liver metastases
Comparative study of total-body PET and PET/MR in the diagnosis of liver metastases
ObjectiveTo compare the diagnostic differences between total-body PET/CT (positron emission tomography/computed tomography) and PET/MR (positron emission tomography/magnetic resona...
68Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters
68Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters
Background
Gliomas are the most common primary central nervous system tumors, of which the malignant gliomas account for 60%–75%. The primary and secondary brain malign...
FAPα+CAFs: Targeting the Tumor Microenvironment for Revolutionary Cancer Therapies
FAPα+CAFs: Targeting the Tumor Microenvironment for Revolutionary Cancer Therapies
Background:
Within the tumor microenvironment (TME), (FAPα+CAFs) referred to as
Cancer-Associated Fibroblasts (CAFs) that express Fibroblast Activation Protein α (FAPα) have
gained...
[68Ga]-DOTATOC PET/CT Volumetric Parameters Reflect Metastatic Potential in Pancreatic Neuroendocrine Tumors
[68Ga]-DOTATOC PET/CT Volumetric Parameters Reflect Metastatic Potential in Pancreatic Neuroendocrine Tumors
Background: [68Ga]-DOTATOC PET/CT is a valuable technique for identifying neuroendocrine tumors overexpressing somatostatin receptors; however, its diagnostic and prognostic utilit...
68Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
68Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
The study aimed to summarize clinical characteristics associated with Gallium-68-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (68Ga-PS...

